Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial.

Kita, Toshihiro; Kaji, Yoshikazu; Kitamura, Kazuo

Kita, Toshihiro; Kaji, Yoshikazu; Kitamura, Kazuo.

Affiliation

Kita T; Division of Circulatory and Body Fluid Regulation, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kaji Y; Souseikai Hakata Clinic, Fukuoka, Japan.
Kitamura K; Division of Circulatory and Body Fluid Regulation, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Drug Des Devel Ther ; 14: 1-11, 2020.

Article in En | MEDLINE | ID: mdl-32021087

Subject(s)

Adrenomedullin/adverse effects; Adrenomedullin/pharmacokinetics; Adrenomedullin/administration & dosage; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Drug Compounding; Drug Tolerance; Healthy Volunteers; Humans; Injections, Intravenous; Male; Middle Aged; Young Adult

Key words

Phase 1 clinical trial; adrenomedullin; clinical pharmacology; inflammatory bowel disease

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenomedullin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google